JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KOELLEL, G. B.
Right arrow Articles by BINZER, B. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KOELLEL, G. B.
Right arrow Articles by BINZER, B. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 87, Issue 4, 421-434, 1946
Copyright © 1946 by American Society for Pharmacology and Experimental Therapeutics


THE RELATIONSHIP BETWEEN CHOLINESTERASE INHIBITION AND THE PHARMACOLOGICAL ACTION OF DI-ISOPROPYL FLUOROPHOSPHATE (DFP)

GEORGE B. KOELLEL 1, ALFRED GILMAN 1, and BERTHA D. BINZER 1

1 Pharmacology Section, Medical Division, Edgewood Arsenal, Maryland

1. Rats, dogs and monkeys appeared to show no physiological abnormality when the cholinesterase of the blood and tissues was reduced to a low percentage of its normal activity by di-isopropyl fluorophosphate. The signs associated with further reduction are described.

2. It was found that determinations of serum and red cell cholinesterase inhibition following the administration of di-isopropyl fluorophosphate do not provide accurate estimates of the activity of the enzyme in the tissues, excepting possibly during the period immediately following a single dose. Such measurements can be used advantageously to follow rates of absorption.

3. No deterioration was detected in solutions of di-isopropyl fluorophosphate in peanut oil following autoclaving for one hour or storage at room temperature for one year.

4. The concentration of a peanut oil solution of di-isopropyl fluorophosphate had little effect on its rate of absorption from an intramuscular site in dogs.

5. The effective intramuscular:oral dosage ratio for di-isopropyl fluorophosphate in peanut oil was found to be approximately 1:4 in monkeys and humans.

Submitted on February 7, 1946




This article has been cited by other articles:


Home page
Arch OphthalmolHome page
I. H. LEOPOLD and P. R. McDONALD
DI-ISOPROPYL FLUOROPHOSPHATE (D F P) IN TREATMENT OF GLAUCOMA: Further Observations
Arch Ophthalmol, August 1, 1948; 40(2): 176 - 188.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1946 by the American Society for Pharmacology and Experimental Therapeutics.